- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CAR-T cell therapy: a potential new strategy against prostate cancer ; volume:7 ; number:1 ; day:16 ; month:10 ; year:2019 ; pages:1-11 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (16.10.2019), 1-11, 12.2019
- Urheber
-
Schepisi, Giuseppe
Cursano, Maria Concetta
Casadei, Chiara
Menna, Cecilia
Altavilla, Amelia
Lolli, Cristian
Cerchione, Claudio
Paganelli, Giovanni
Santini, Daniele
Tonini, Giuseppe
Martinelli, Giovanni
De Giorgi, Ugo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0741-7
- URN
-
urn:nbn:de:101:1-2020021219435843748204
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schepisi, Giuseppe
- Cursano, Maria Concetta
- Casadei, Chiara
- Menna, Cecilia
- Altavilla, Amelia
- Lolli, Cristian
- Cerchione, Claudio
- Paganelli, Giovanni
- Santini, Daniele
- Tonini, Giuseppe
- Martinelli, Giovanni
- De Giorgi, Ugo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting NR4As, a new strategy to fine-tune CAR-T cells against solid tumors
High-affinity antiviral CAR-T cells against HCMV-reactivation
Engineering CAR-T cells
FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Switchable CAR T cell strategy against osteosarcoma
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer
Strategies to enhance CAR-T persistence
Gut microbiome and CAR-T therapy
Target selection for CAR-T therapy
Targeting NR4As, a new strategy to fine-tune CAR-T cells against solid tumors
High-affinity antiviral CAR-T cells against HCMV-reactivation
Engineering CAR-T cells
FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Switchable CAR T cell strategy against osteosarcoma
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer
Strategies to enhance CAR-T persistence
Gut microbiome and CAR-T therapy
Target selection for CAR-T therapy
Targeting NR4As, a new strategy to fine-tune CAR-T cells against solid tumors
High-affinity antiviral CAR-T cells against HCMV-reactivation
Engineering CAR-T cells
FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Switchable CAR T cell strategy against osteosarcoma
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer
Strategies to enhance CAR-T persistence
Gut microbiome and CAR-T therapy